Insider trading

Period: 120 months Stock: AMRN + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

98 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

98 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

98 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

98 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
98 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
98 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

98 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
2 Aug 2024
Berg Aaron President and CEO
Bought
$102.40K 160,000 at 0.64
24.8%
First buy on file
22 Jan 2024
Holt Patrick President and CEO
Bought
$15.72K 14,426 at 1.09
4.8%
12 Dec 2023
Ketchum Steven B Chief Scientific Officer
Sold on a plan
$26.96K 34,131 at 0.79
5.7%
Planned (10b5-1)
16 Aug 2023
Holt Patrick President and CEO
Bought 7×
$312.32K 300,000 at 1.04
opened
First buy on file
13 Jun 2022
WOLD OLSEN PER Director
Bought
$92.73K 55,000 at 1.69
58.5%
First buy on file
15 Dec 2021
Bought
$6.31K 2,000 at 3.16
1.0%
14 Dec 2021
Bought
$32.69K 10,000 at 3.27
5.4%
First buy on file
12 Aug 2021
Kalb Michael Wayne SVP and CFO
Sold, plan not stated
$630.24K 120,000 at 5.25
36.9%
4 Jun 2021
STACK DAVID M Director · indirect
Bought
$45.35K 10,000 at 4.54
33.3%
+33% of stake
3 Jun 2021
STACK DAVID M Director · indirect
Bought
$23.12K 5,000 at 4.62
20.0%
+20% of stake
1 Feb 2021
Ketchum Steven B Chief Scientific Officer
Sold, plan not stated 2×
$1.75M 217,728 at 8.06
36.2%
27 Jan 2021
Ketchum Steven B Chief Scientific Officer
Sold, plan not stated 2×
$3.38M 421,629 at 8.01
52.1%
Sold half or more
30 Nov 2020
STACK DAVID M Director · indirect
Bought
$121.52K 25,000 at 4.86
opened
First buy on file
11 Nov 2020
THERO JOHN F President and CEO
Sold, plan not stated
$1.68M 413,565 at 4.07
13.1%
10 Nov 2020
THERO JOHN F President and CEO
Sold, plan not stated
$635.97K 153,840 at 4.13
4.7%
4 Mar 2020
THERO JOHN F President and CEO
Sold, plan not stated
$3.20M 200,000 at 15.99
7.5%
3 Jan 2020
Sold, plan not stated
$6.28M 300,000 at 20.94
78.0%
Sold half or more
16 Dec 2019
Sold, plan not stated
$2.58M 100,000 at 25.83
54.2%
Sold half or more
16 Dec 2019
Berg Aaron CHIEF COMMERCIAL OFFICER
Sold, plan not stated
$1.10M 43,253 at 25.46
24.4%
16 Dec 2019
Kalb Michael Wayne SVP and CFO
Sold, plan not stated 4×
$584.01K 25,000 at 23.36
53.7%
Sold half or more
19 Nov 2019
THERO JOHN F President and CEO
Sold, plan not stated
$6.22M 274,454 at 22.65
10.5%
12 Nov 2019
Ekman Lars Director
Sold, plan not stated
$746.76K 38,600 at 19.35
100%
Sold half or more
11 Nov 2019
THERO JOHN F President and CEO
Sold, plan not stated 2×
$8.14M 475,546 at 17.12
15.4%
5 Nov 2019
Ekman Lars Director
Sold, plan not stated
$115.23K 6,400 at 18.00
100%
Sold half or more
3 Sep 2019
Ekman Lars Director
Sold, plan not stated
$1.37M 91,016 at 15.01
100%
Sold half or more
11 Jul 2019
STACK DAVID M Director · indirect
Sold, plan not stated
$1.16M 51,991 at 22.28
100%
Sold half or more
5 Jul 2019
Sold, plan not stated
$2.38M 100,000 at 23.82
54.2%
Sold half or more
3 Jul 2019
Berg Aaron CHIEF COMMERCIAL OFFICER
Sold, plan not stated
$662.24K 29,250 at 22.64
44.6%
2 Jul 2019
Berg Aaron CHIEF COMMERCIAL OFFICER
Sold, plan not stated 2×
$1.44M 69,564 at 20.73
65.7%
Sold half or more
1 Jul 2019
Kennedy Joseph T General Counsel
Sold, plan not stated
$1.06M 54,186 at 19.52
63.4%
Sold half or more
1 Jul 2019
Kalb Michael Wayne SVP and CFO
Sold, plan not stated
$983.27K 50,000 at 19.67
70.6%
Sold half or more
24 Jun 2019
Berg Aaron CHIEF COMMERCIAL OFFICER
Sold, plan not stated
$2.10M 113,195 at 18.59
75.7%
Sold half or more
18 Jun 2019
Sold, plan not stated
$1.90M 100,000 at 19.02
54.2%
Sold half or more
31 May 2019
Kennedy Joseph T General Counsel
Sold, plan not stated
$488.06K 27,229 at 17.92
46.6%
29 May 2019
STACK DAVID M Director
Sold, plan not stated
$623.53K 33,799 at 18.45
100%
Sold half or more
17 May 2019
STACK DAVID M Director
Sold, plan not stated
$237.14K 13,174 at 18.00
100%
Sold half or more
30 Apr 2019
Kennedy Joseph T General Counsel
Sold, plan not stated
$508.84K 27,230 at 18.69
46.6%
30 Apr 2019
Ketchum Steven B Chief Scientific Officer
Sold, plan not stated
$178.11K 9,541 at 18.67
2.6%
1 Apr 2019
Kennedy Joseph T General Counsel
Sold, plan not stated
$1.06M 53,060 at 20.03
62.1%
Sold half or more
1 Apr 2019
Ketchum Steven B Chief Scientific Officer
Sold, plan not stated 2×
$191.39K 9,542 at 20.06
2.6%
1 Apr 2019
Kennedy Joseph T General Counsel
Bought
$23.13K 1,112 at 20.80
3.7%
First buy on file
4 Mar 2019
THERO JOHN F President and CEO
Sold, plan not stated 2×
$5.33M 250,000 at 21.31
10.7%
4 Mar 2019
Ekman Lars Director
Sold, plan not stated 2×
$2.88M 135,377 at 21.31
100%
Sold half or more
1 Mar 2019
Kalb Michael Wayne SVP and CFO
Sold, plan not stated 3×
$2.21M 100,000 at 22.09
83.0%
Sold half or more
1 Mar 2019
Ketchum Steven B Chief Scientific Officer
Sold, plan not stated 3×
$1.02M 46,000 at 22.09
11.5%
28 Feb 2019
Kennedy Joseph T General Counsel
Sold, plan not stated
$564.17K 27,231 at 20.72
46.6%
28 Feb 2019
Ketchum Steven B Chief Scientific Officer
Sold, plan not stated
$197.25K 9,543 at 20.67
2.6%
22 Feb 2019
VAN HEEK G JAN Director
Sold, plan not stated
$4.07M 203,382 at 20.02
93.5%
Sold half or more
22 Feb 2019
Sold, plan not stated
$3.59M 180,625 at 19.90
68.1%
Sold half or more
22 Feb 2019
Sold, plan not stated
$3.27M 163,500 at 20.02
100%
Sold half or more
Showing 1–50 of 98. Page 1 of 2 Older →